Literature DB >> 11993605

The limits of tamoxifen.

M J Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11993605     DOI： 10.1007/bf03168929

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  7 in total

1.  Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.

Authors:  J C Gazet; C Markopoulos; H T Ford; R C Coombes; J M Bland; R C Dixon
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

2.  Tamoxifen as the primary treatment in elderly patients with breast cancer.

Authors:  S B Hooper; A D K Hill; S Kennedy; B Dijkstra; L M Kelly; E W M McDermott; N O'Higgins
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

3.  Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast.

Authors:  M W Reed; J M Morrison
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

4.  Surgery for carcinoma of the breast in women over 70 years of age.

Authors:  E Amsterdam; S Birkenfeld; A Gilad; M Krispin
Journal:  J Surg Oncol       Date:  1987-07       Impact factor: 3.454

5.  The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer.

Authors:  C J Newschaffer; L Penberthy; C E Desch; S M Retchin; M Whittemore
Journal:  Arch Intern Med       Date:  1996-01-08

6.  Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

Authors:  J F Robertson; J H Todd; I O Ellis; C W Elston; R W Blamey
Journal:  BMJ       Date:  1988 Aug 20-27

7.  The effect of comorbidity on 3-year survival of women with primary breast cancer.

Authors:  W A Satariano; D R Ragland
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.